Switching innovation: Turning ‘corporate antibodies’ into corporate allies
Human nature’s resistance to change is well-known. We tend to cling to what is familiar … known … safe. The same is true within organisations.
After all, change management programmes exist for a reason. But, similarly, we all know the saying, “Insanity … doing the same thing over and over again and expecting different results.”
Innovation, by its very nature, calls for new, different, fresh, and out-the-box thinking and practices. With futurists predicting more change in the next 20 years than the last 300, innovation has long been heralded as vital for organisational survival.
So how do we marry the two? How do we facilitate innovation, ingraining an innovative culture within organisations, on the back of human nature’s need to stick to what is known? While it’s key to balance the dynamic between too much resistance and too much enthusiasm, as vital to success is winning over ‘corporate antibodies’, which are described by the Harvard Business Review as “individuals that extinguish a new idea as soon as it begins to course through the organisation”. Read more